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Regulatory mechanisms of interleukin-10 (IL10)-producing
B cells in mucosal homeostasis are not fully understood.
This study shows that IL10-secreting B cells activated by
resident bacteria ameliorate T-cell-mediated colitis by
inducing T regulatory-1 cells via an IL27-dependent
mechanism.
BACKGROUND & AIMS: The regulatory roles of interleukin-10
(IL10)-producing B cells in colitis are not fully understood, so
we explored the molecular mechanisms by which these cells
modulate mucosal homeostasis.
METHODS: CD4þ T cells from wild-type (WT), Il10/, or
Il27ra/ mice were cotransferred with B cells from speciﬁc
pathogen-free (SPF) or germ-free (GF) WT or Il10/ mice into
Rag2/Il10/(double-knockout) mice, and the severity of co-
litis and intestinal regulatory T-cell populations were character-
ized. In vitro, WT or Il10/ B cells were cocultured with
unfractionated, naïve or regulatory T cells plus Il10/ antigen-
presenting cells and stimulated with cecal bacterial lysate (CBL)
with or without IL27 or anti-IL10R blockade. Gene expressions,
cytokines in the supernatant and cell populations were assessed.
RESULTS: WT but not Il10/ B cells attenuated T helper cell
TH1/TH17-mediated colitis in double-knockout mice that also
received WT but not Il10/ T cells. In vitro, CBL-stimulated
WT B cells secrete abundant IL10 and suppress interferon-g
(IFNg) and IL17a-production by T cells without requiring cell
contact. Although both WT and Il10/ B cells induced
Foxp3þCD4þ T-regulatory cells, only WT B cells induced IL10-
producing (Foxp3-negative) T regulatory-1 (Tr-1) cells both
in vivo and in vitro. However, IL10-producing B cells did not
attenuate colitis or induce Tr-1 cells in the absence of T cell
IL27 signaling in vivo. WT B cell-dependent Tr-1 induction and
concomitant decreased IFNg-secretion were also mediated by
T-cell IL27-signaling in vitro.
CONCLUSIONS: IL10-secreting B cells activated by physiologi-
cally relevant bacteria ameliorate T-cell-mediated colitis and
contribute to intestinal homeostasis by suppressing effector T
cells and inducing Tr-1 cells via IL27-signaling on T cells. (Cell
Mol Gastroenterol Hepatol 2015;1:295–310; http://dx.doi.org/
10.1016/j.jcmgh.2015.01.002)Keywords: Experimental Colitis; IBD; Immunoregulation; Reg-
ulatory B Cells.
nﬂammatory bowel diseases (IBD) are chronic, T-cell-Imediated intestinal disorders characterized by loss of
tolerance to resident enteric bacteria and aggressive in-
ﬂammatory responses.1,2 Regulatory T cells (Treg) have a
well-described role in attenuating experimental colitis and
IBD. Treg help maintain intestinal homeostasis by prevent-
ing inappropriate innate and adaptive immune responses
against resident bacteria. CD4þ T cells that express forkhead
box P3 (Foxp3) and T regulatory-1 (Tr-1) cells that lack
Foxp3 expression (Foxp3neg), but produce interleukin-10
(IL10) comprise major regulatory T-cell populations in the
intestine.3,4 CD25þFoxp3þCD4þ Treg prevent colitis in se-
vere combined immunodeﬁciency mice cotransferred with
CD45RBhigh T cells,5 and enteric bacterial antigen-speciﬁc
Tr-1 cells ameliorate colitis induced by pathogenic T help-
er 1 (TH1) cells.
6
In parallel with Treg cells, B cells contribute to intestinal
homeostasis by secreting immunoglobulins that decrease
mucosal translocation of luminal bacteria and producing
regulatory cytokines that inhibit effector mucosal immune
responses.7 Moreover, antigen presentation by B cells pro-
motes the differentiation of tolerogenic CD4þ T cells.8 B-cell
depletion may contribute to the development of human
IBD9 and potentiate murine experimental colitis,10 sug-
gesting that B cells are protective in IBD. However, the
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mation are not entirely clear.
B cells secrete IL10 as do many other cell types including
Treg cells, macrophages, mast cells, epithelial cells, and
dendritic cells. IL10 reduces inﬂammation by inhibiting
effector T-cell activation.11 IL10-deﬁcient (Il10/) and
IL10-receptor-deﬁcient mice develop resident enteric
bacteria-dependent TH1/TH17-mediated colitis.
12 The role
of IL10 derived from intestinal T-cells and myeloid cells in
maintaining mucosal homeostasis is well studied, but rela-
tively little is known about the importance of IL10-
producing B cells in IBD and experimental colitis.9,10,13,14
Moreover, the mechanisms of how IL10-producing B cells
potentially maintain mucosal homeostasis in the intestine
are poorly understood.
IL27, a member of the IL12 family, consists of Epstein-
Barr virus induced gene-3 (EBI3) and p28 subunits and
has pleiotropic effects on the immune system. IL27 was
originally reported to induce TH1 cell development,
15 but it
can also suppress the development of TH17 cells by
decreasing Rorgt gene expression and increasing the num-
ber of IL10-producing Tr-1 cells but not Foxp3þ Treg.16–20
IL27 promotes the expansion of Tr-1 cells by up-
regulating c-Maf and aryl hydrocarbon receptor in naïve T
cells.20 There is conﬂicting evidence regarding the role of
IL27 in colitis, with some studies showing that IL27 has
proinﬂammatory effects21–23 and others demonstrating that
IL27 is anti-inﬂammatory.24–26 Thus, IL27 likely plays a
pivotal role in regulating the delicate balance between
proinﬂammatory TH1/TH17 cells and anti-inﬂammatory
IL10-producing T-cell populations in the intestine. Howev-
er, it is unknown whether IL10-producing mucosal B cells
affect the regulatory or proinﬂammatory functions of IL27.
This study addresses the mechanisms by which IL10-
secreting B cells inﬂuence regulatory T-cell differentiation
and ameliorate T-cell-mediated colitis. We show that
IL10-producing B cells suppress wild-type (WT) but not
Il10/CD4þ T-cell-mediated colitis and are associated with
increased frequency of intestinal Tr-1 cells and decreased
TH1/TH17 cytokine proﬁles. Moreover, we demonstrate that
regulatory functions of IL10-secreting B cells are mediated
by IL27-signaling in T cells. Together, these ﬁndings eluci-
date novel regulatory mechanisms of IL10-secreting B cells,
help explain mechanisms of mucosal homeostasis, and could
be exploited to treat IBD.Materials and Methods
Mice
We purchased C57BL/6 (B6).WT, B6.Il10/, B6.Rag2/,
and B6.Il27ra (WSX-1)/ mice from Jackson Laboratories
(Bar Harbor, ME). We purchased 129S6/SvEv (129).WT mice
from Taconic Farms (Germantown, NY). The 129.Il10/
mice were obtained from Dr Donna Rennick (DNAX Labora-
tories, Palo Alto, CA). The Il10/Rag2/ double-knockout
(DKO) mice were generated by crossing B6.Il10/ with
B6.Rag2/ mice or 129.Il10/ with 129.Rag2/ mice.
The B6.Il10þ/EGFP reporter (Vert-X) mice were obtained
from Dr Christopher Karp.27 These mice were originallymaintained in the speciﬁc pathogen-free (SPF) facility at
the University of North Carolina (UNC), then all 129
strains, B6.WT, Il10/, DKO, and Vert-X mice were derived
into germ-free (GF) conditions by embryo transfers, and
breeding colonies were established in the GF facility at the
UNC. Afterward, the mice were transferred to a SPF room
and colonized with SPF feces to maintain SPF colonies. The
mice used in this study were born from parents that had
also been born and raised in SPF conditions over six gen-
erations, and they were used at 8 to 16 weeks of age. These
studies were approved by the UNC–Chapel Hill Institu-
tional Animal Care and Use Committee (ACUC) Protocol no.
12–300.0.
Cell Isolation
Mononuclear cells were isolated from the colon lamina
propria (LP), mesenteric lymph nodes (MLN), and spleen, as
described elsewhere.13 The MLN were pressed through
70-mm ﬁlters into phosphate-buffered saline (PBS) with
2.5% fetal bovine serum (Gibco/Invitrogen, Carlsbad, CA).
Spleens were mechanically dissociated, and the red blood
cells were lysed with red blood cell lysing buffer (Sigma-
Aldrich, St. Louis, MO). For isolation of colonic LP lympho-
cytes (LPL), the large intestines were washed with cold PBS,
opened longitudinally, and cut into 10-mm pieces. Then the
intestines were incubated in 1 mM dithiothreitol (Sigma-
Aldrich) in Ca2þ- and Mg2þ-free Hanks’ balanced salt solu-
tion (HBSS; Gibco/Invitrogen) for 15 minutes at room
temperature. Next, the tissues were incubated in 1 mM
EDTA (Sigma-Aldrich) in HBSS for 20 minutes at 37C with
shaking, which was repeated after a thorough washing. The
cell suspensions were removed, and the remaining frag-
ments were transferred to ﬂasks containing HBSS with
1 mg/mL of collagenase type 3 (Sigma-Aldrich) and 1%
penicillin-streptomycin (Gibco/Invitrogen), then stirred
gently for 60 minutes at 37C. The cell suspensions con-
taining LPL were ﬁltered through a nylon mesh and
centrifuged, then the LPL were puriﬁed using a 44%–70%
discontinuous Percoll gradient (GE Healthcare, Buck-
inghamshire, UK). After centrifugation at 800g for 20
minutes at 22C, the mononuclear cells were collected from
the interface.
Cell Puriﬁcation
Splenic B cells were puriﬁed magnetically by positive
selection with anti-CD19 microbeads after negative selec-
tion by a mixture of anti-CD90.2, anti-CD11c, and anti-
Ter119 microbeads (Miltenyi Biotec, Auburn, CA) (greater
than 99.5% pure and 90% viable). The CD4þ T cells
were isolated by a CD4þ T-cell isolation kit (Miltenyi Biotec)
(more than 94.7% pure and 95% viable). In some
experiments, unfractionated CD4þ T cells were further
fractionated into CD25þ and CD25 T cells by PE-
conjugated anti-CD25 antibody with anti-PE microbeads.
Red blood cell lysed-unfractionated splenocytes from
(Il10þ/þ)Rag2/ and DKO mice were used for WT and
Il10/ antigen-presenting cells (APC), respectively (more
than 88.4% CD11bþ).
Table 1.Polymerase Chain Reaction Primers Used in this Study
Gene Sense 50-30 Antisense 50-30 Reference
Il27p28 GGCCAGGTGACAGGAGACC CAGCTTGTACCAGAAGCAAGGG Collison et al41
Ebi3 AGCAGCAGCCTCCTAGCCT ACGCCTTCCGGAGGGTC Collison et al41
Il12a TGGCTACTAGAGAGACTTCTTCCACAA GCACAGGGTCATCATCAAAGAC Collison et al41
Il23a ATCCAGTGTGAAGATGGTTGTGA GCAAGCAGAACTGGCTGTTG Collison et al41
Il17a CTCCAGAAGGCCCTCAGACTAC AGCTTTCCCTCCGCATTGACACAG Qu et al42
Il6 CCGGAGAGGAGACTTCACAG TCCACGATTTCCCAGAGAAC Bao et al43
Cmaf AAATACGAGAAGCTGGTGAGCAA CGGGAGAGGAAGGGTTGTC Hiramatsu et al44
Ahr ACATCACCTATGCCAGCCGC TCTGTGTCGCTTAGAAGGAT Wurster et al45
Il21 AAGATTCCTGAGGATCCGAGAAG GCATTCGTGAGCGTCTATAGTGTC Wurster et al45
Foxp3 GGCCCTTCTCCAGGACAGA GCTGATCATGGCTGGGTTGT Wan and Flavell46
Rorgt TGAGGCCATTCAGTATGTGG CTTCCATTGCTCCTGCTTTC Ano et al47
Tbet TTCCCATTCCTGTCCTTCAC CCACATCCACAAACATCCTG Ano et al47
Actb AGCCATGTACGTAGCCATCCAG TGGCGTGAGGGAGAGCATAG Liu et al28
Blimp1 TTCTTGTGTGGTATTGTCGGGACTT TTGGGGACACTCTTTGGGTAGAGTT Miyauchi et al48
Il12b CGCAAGAAAGAAAAGATGAAGGAG TTGCATTGGACTTCGGTAGATG Made ourselves
Ifng CTTCCTCATGGCTGTTTCTGG CGCTTATGTTGTTGCTGATGG Made ourselves
Il10 GTCATCGATTTCTCCCCTGTG CCTTGTAGACACCTTGGTCTTGG Made ourselves
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The 5  105 unfractionated splenic CD4þ T cells from
129.WT or Il10/ mice were cotransferred intraperitone-
ally with or without 1  106 B cells from 129.WT or Il10/
mice into 129.DKO mice. The 5  105 CD25CD4þ T cells
from B6.WT, Il27ra/, or Vert-X mice were injected intra-
peritoneally into B6.DKO mice with or without 1  106 B
cells from B6.WT or Il10/ donors. The severity of colitis
and intestinal cell populations were assessed 3 to 6 weeks
after the cell transfer.Assessment of Colitis
We evaluated the severity of colitis by blinded histologic
scoring, colonic tissue explant cultures, and MLN cell cul-
tures, as described elsewhere.28
Blinded histologic scoring. Intestinal tissues were
removed and ﬁxed in 10% buffered formalin. Histologic
inﬂammation was quantiﬁed in parafﬁn-embedded, H&E-
stained sections of cecum, proximal colon, and distal co-
lon in a blinded fashion, with each region being graded
from 0 to 4 based on the degree of LP and submucosal
mononuclear cellular inﬁltration, crypt hyperplasia,
goblet cell depletion, and architectural distortion. The
total histology score represents the summation of the
scores for cecum, proximal colon, and distal colon
(maximum score 12).
Colonic tissue explant cultures. Colonic tissues ware
thoroughly washed with cold PBS, shaken at room tem-
perature in RPMI containing 50 mg/mL gentamicin for 30
minutes at 280 rpm, cut into 0.5-cm fragments, and
weighed. Colonic tissue fragments were distributed (0.05 g
per well) into 24-well plates and incubated in 1 mL of RPMI
1640 medium supplemented with 5% fetal bovine serum,
50 mg/mL gentamicin, and 1% antibiotic/antimycotic(penicillin/streptomycin/amphotericin B; GIBCO, Grand
Island, NY) for 20 hours at 37C. Supernatants were
collected and stored at 20C before use for cytokine
quantiﬁcation.
Mesenteric lymph node cell cultures. The 5  105
unfractionated MLN cells of individual recipient animals
were stimulated in 96-well ﬂat-bottom plates with 10 mg/mL
CBL at 37C, 5% CO2 in a humidiﬁed incubator. After 72
hours, the culture supernatants were collected for cytokine
assays.
Cecal Bacterial Lysate
Cecal bacterial lysate (CBL) was prepared from the
contents of ceca from SPF B6 or 129.WT mice as described
elsewhere.28 The protein concentration of the lysate was
determined, and the cells were stimulated with 10 mg/mL of
protein. We used B6.CBL and 129.CBL in the culture me-
dium with the cells puriﬁed from B6 and 129 mice,
respectively.
B Cell, T Cell, and Antigen-Presenting
Cell Cultures
The 2.5  105 unfractionated CD4þ T cells isolated
from 129.WT or Il10/ mice were cocultured with
5  105 129.WT or Il10/ B cells along with 2  105
129.Il10/ APC at 200 mL/well (96-well plates) for 72
hours at 37C with 5% CO2. In some experiments, 5  105
naïve WT CD25 with or without 2.5  105 CD25þCD4þ T
cells from 129.WT or Il10/ mice were cocultured with
or without 1  106 129.WT or Il10/ B cells along
with 2  105 129.Il10/ APC. In selected experiments,
2.5  105 CD25CD4þ T cells isolated from Vert-X mice,
Il27ra/, or (Il27raþ/þ) WT mice were cocultured with
5  105 B6.WT or Il10/ B cells along with 2  105
Figure 1. IL10-secreting B cells ameliorate intestinal inﬂammation. The 5  105 129.WT (wild type) unfractionated CD4þ T
cells were cotransferred with or without 1  106 B cells from 129.WT or Il10/ knockout (KO) mice into speciﬁc pathogen-free
(SPF) 129.Rag2/Il10/ mice. Six weeks later, colonic inﬂammation was quantiﬁed by (A) histology (total and segmental
scores), photomicrographs (B), and cytokine-secretion from unstimulated colon explant cultures (C) and from cecal bacterial
lysate (CBL)-stimulated mesenteric lymph nodes (MLN) cell cultures (D). MLN cells were evaluated for (E) the reconstitution of
CD4þ T cells (CD3þCD4þ) and B cells (CD19þB220þ) and (F) the frequency of Foxp3þCD4þ T-regulatory cells by ﬂow
cytometry. mRNA level of Foxp3 in the distal colon was assessed by real-time polymerase chain reaction. N ¼ 6–7/group, two
replicates. Data are presented as mean ± standard error. *P < .05; **P < .01; ***P < .001.
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from B6 (Il10þ/þ) Rag2/ or Il10/Rag2/ mice were
cocultured without or with 5  106 B cells from B6 WT or
Il10/ mice.
In another experiment, 5  105 naïve T cells isolated
from Vert-X mice and 5  105 B6.Il10/ APC were cocul-
tured without or with 1  106 B6.WT or Il10/ B cells at
400 mL/well using 48-well transwell plates (0.4-mm pore
size) (Costar, Corning, NY). The culture medium was
RPMI 1640 (Gibco/Invitrogen) containing 10% fetal
bovine serum, 1% penicillin/streptomycin/amphotericin B
(Gibco/Invitrogen), and 5  105 mol/L 2-mercapt ethanol(Sigma-Aldrich), with 10 mg/mL CBL from either WT 129 or
B6 mice or without bacterial lysates.
In selected experiments, 10 mg/mL anti-IL10R neutralizing
antibody (BD Biosciences, San Jose, CA), anti-IL27 neutralizing
antibody (eBioscience, San Diego, CA), isotype control [puri-
ﬁed rat IgG1 (BD Biosciences) or mouse IgG2a (eBioscience)],
or recombinant murine IL10 or IL27 at 10, 1, or 0.1 ng/mL
(PeproTech, Rocky Hill, NJ) was added. After 72 hours, the
supernatants were collected for measurement of cytokines by
enzyme-linked immunosorbent assay (ELISA), and cells were
analyzed by ﬂow cytometry. For bacteria-activated T-cell RNA
analysis, CBL-stimulated naïve T cells were reisolated using a
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hours after coculture with B cells and APC.
Cytokine Measurements
To evaluate the production of cytokines, ELISAs were
performed by the Immunoassay Core of the CGIBD at UNC
according to the manufacturer’s instructions with the
following products: mouse anti-IL10, IL12/23p40, inter-
feron-g (IFNg), and IL17 (BD Biosciences), and IL27
(eBioscience). Concentrations of cytokines were established
in triplicate culture supernatants by comparison with
standard curves generated using the appropriate recombi-
nant cytokine.
Real-Time Polymerase Chain Reaction
Total RNA was isolated from reisolated CD4þ cells using
RNeasy Micro Kit (Qiagen, Valencia, CA) and real-time po-
lymerase chain reaction (RT-PCR) was performed as
described elsewhere.28 The primer sequences used in this
study are shown in Table 1.
Flow Cytometry
The antibodies we used in this study were anti-mouse
CD4, CD19, CD45, B220, CD3, F4/80, CD11c, CD11b
(BD Bioscience), IL10, IL17, IFNg, IL27p28, and Foxp3
(eBioscience), eBi3 (R&D Systems, Minneapolis, MN), and
live/dead cell viability kits (Invitrogen/Life Technologies,
Carlsbad, CA). MLN, or colonic LP cells were collected and
incubated for 15 minutes at 4C with anti-CD16/CD32
(BD Bioscience) and then for 20 minutes at 4C with an-
tibodies for cell surface and live/dead cell viability kits to
evaluate the cell phenotype and CD4þ T-cell/B-cell
reconstitution.
Enumeration of cells expressing IL10, IL17, IFNg,
IL27p28, Ebi3, and Foxp3 was performed by intracellular
staining with a ﬁxation and permeabilization solution kit (BD
Bioscience) according to the manufacturer’s instructions. For
intracellular cytokine staining, 100 ng/mL phorbol myristateFigure 2. IL10-secreting B cells regulate intestinal inﬂammat
cells from SPF 129.WT or Il10/ knockout (KO) mice were co
129.WT or Il10/ mice into SPF 129.Rag2/Il10/ mice. Six-w
IFNg-secretion in colon explant cultures (B) were measured. N ¼
*P < .05, **P < .01, ***P < .001 (n ¼ 6–7/group). N.S: not statisacetate, 1 mg/mL ionomycin (Sigma-Aldrich), and GolgiStop
(BD Biosciences) were added into the medium during the last
4 hours of the culture period. The cells were washed and
then analyzed on a CyAn ﬂow cytometer (Beckman Coulter,
Brea, CA). Proper isotype antibodies were used as a control,
and gated live CD45þ cells were analyzed with Summit 5.2
software (Beckman Coulter).Statistical Analysis
Statistical analysis was performed using Prism 5 soft-
ware (GraphPad, San Diego, CA) to compare the mean
between two groups with two-tailed, unpaired Student’s
t tests; comparisons of the mean from multiple groups were
analyzed with one-way analysis of variance (ANOVA) and
the Bonferroni posttest. P < .05 was considered statistically
signiﬁcant.Results
Interleukin-10-Producing B Cells Attenuate
T-Cell-Mediated Colitis via Interleukin-10
Secreting T Cells
To evaluate the role of IL10-producing B cells in regu-
lating colitis in vivo, we cotransferred SPF 129.WT or
Il10/CD4þ T cells with or without B cells from 129.WT or
Il10/ mice into 129.Rag2/Il10/ (DKO) recipients in
SPF conditions. The DKO mice that received unfractionated
WT CD4þ T cells developed moderate TH1/TH17-mediated
colitis by 6 weeks as assessed by histologic scores
(Figure 1A and 1B) and spontaneous IFNg and IL17a-
secretion by colonic tissue explants (Figure 1C); the
cotransferred WT, but not Il10/, B cells suppressed all
measured parameters of inﬂammation. Spontaneous secre-
tion of IL10 in colonic explant cultures was increased in the
mice that received WT B cells (Figure 1C). Likewise, CBL-
stimulated MLN cells from mice that received WT B cells
secreted more IL10 and less IFNg and IL17a compared with
mice that received Il10/ or no B cells (Figure 1D).ion in the presence of T-cell-derived IL10. 5  105 CD4þ T
transferred with or without different numbers of B cells from
eeks later, histologic total colon inﬂammation scores (A) and
6–7/group, two replicates. Data are presented as mean ± SE,
tically signiﬁcant.
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from mice that received WT B cells were not statistically
signiﬁcantly different compared with the percentages in
those that received Il10/ B cells (Figure 1E). The per-
centages of MLN Foxp3þCD4þ Treg and Foxp3 mRNA levels
in the distal colon were statistically signiﬁcantly increased
in the mice that received either WT or Il10/ B cells
compared with the mice that did not receive B cells
(Figure 1F). On the other hand, cotransfer of WT B cells
had no effect on histologic inﬂammation or IFNg-secretion
by colonic tissue explants in mice that received Il10/
CD4þ T cells even when 10 times more WT B cells were
transferred (Figure 2A and B), suggesting that IL10-
producing B cells inhibit experimental colitis caused byFigure 3. Germ-free (GF) wild-type (WT) B cells have anti-in
(SPF) WT B cells, but GF Il10L/L B cells are unable to reg
CD25-CD4þ T cells from GF B6.WT mice were cotransferred wit
knockout (KO) mice into SPF B6.Rag2/Il10/ mice. Six week
total histologic scores and cytokine measurement by colonic tis
(SE), *P < .05. (B) In vitro, 2.5  105 splenic CD25-CD4þ T cells fr
cells from B6.WT or Il10/ mice housed in GF or SPF conditio
hours later, cytokines in the supernatant were measured by enz
replicates. Mean ± SE, *P < .05; **P < .01; ***P < .001.T-cell-transfer only when the T cells are capable of
secreting IL10. Moreover, the B cells from the GF and SPF
B6.WT mice exhibited similar anti-inﬂammatory properties
(Figure 3A and B). Our transferred CD19þB220þ popula-
tion that contained mainly naïve B cells, even in SPF mice
(more than 95%), received physiologic bacteria stimulation
in SPF recipients to stimulate IL10-secretion and regula-
tory function. On the other hand, B cells from noninﬂamed
GF and inﬂamed SPF B6.Il10/ mice similarly lacked
anti-inﬂammatory properties in vivo and in vitro, sug-
gesting that the difference in colitis between mice that
received WT versus Il10/ B cells is not due to the pre-
existence of inﬂammation in the Il10/ donor mice
(Figure 3A and B).ﬂammatory properties similar to speciﬁc pathogen-free
ulate intestinal inﬂammation. (A) In vivo, 5  105 splenic
h or without 1  106 B cells from GF or SPF B6.WT or Il10/
s after the cell-transfer, the severity of colitis was assessed by
sue explant cultures. N ¼ 6–7/group. Mean ± standard error
om GF B6.WT mice were cocultured with or without 5  105 B
ns along with 2  105 GF Il10/ Antigen-presenting cells 48
yme-linked immunosorbent assay (ELISA). N ¼ 6/group, two
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Producing B Cells Inhibit Proinﬂammatory
Cytokine-Secretion by T Cells In Vitro
We next sought to determine mechanisms by which
IL10-producing B cells inhibit proinﬂammatory cytokine-
secretion by T cells. We measured cytokines in physiolog-
ical CBL-stimulated cocultures of unfractionated CD4þ T
and B cells from 129.WT or Il10/ mice and Il10/ APC.
We detected increased IL10 in cultures containing WT B
cells and the amounts were even higher when cocultured
with WT or Il10/ T cells (Figure 4A). In cultures con-
taining WT CD4þ cells, the presence of IL10-producing B
cells was associated with decreased levels of IFNg andFigure 4. Cecal bacteria–stimulated interleukin-10 (IL10)-se
similar degree as CD25DCD4D T-regulatory cells in vitro. T
blockade. Cytokine secretion was measured in cecal bacte
unfractionated 129.WT or Il10/ KO (knockout) CD4þ T cells, 5
105 129.Il10/ antigen-presenting cell (APC) by enzyme-linked
selectively added 10 mg/mL IL10 receptor (IL10R) antibody or 5
parallel, IL10 and interferon-g (IFNg) were assessed in CBL-st
Il10/ B cells, and WT or Il10/CD25þCD4þ T-regulatory ce
average numbers of live (live/dead cell staining kit) CBL-stimula
CD25-CD4þ T cells, WT B cells, and WT CD25þCD4þ Treg were
.05; **P < .01; ***P < .001.IL17a compared with cultures that had Il10/ or no B cells
(Figure 4A and 4B). In contrast, consistent with the inability
of WT B cells to attenuate experimental colitis in the
absence of IL10-producing T cells, WT B cells were unable
to suppress IFNg and IL17a when cocultured with Il10/ T
cells (Figure 4A and B). Blockade of IL10-signaling by anti-
IL10R antibody increased IFNg-secretion in the cultures
containing WT CD4þ T cells, WT B cells, and Il10/ APC,
whereas exogenous recombinant-IL10 decreased IFNg and
IL17a-secretion in the cultures containing Il10/CD4þ T
cells, Il10/ B cells with Il10/ APC. These data indicate
that the anti-inﬂammatory function of IL10-producing B
cells may be due in part to their ability to suppress IFNg andcreting B cells suppress proinﬂammatory cytokines to a
his protection is eliminated by interleukin-10 (IL10)-signaling
rial lysate (CBL)-stimulated cultures containing 2.5  105
 105 129.WT (wild type) or Il10/ B cells along with 2.5 
immunosorbent assay (ELISA) (A) and ﬂow cytometry (B). We
ng/mL recombinant IL10. (N ¼ 6/group, three replicates.) In
imulated cultures containing WT CD25-CD4þ T cells, WT or
lls (Treg) by ELISA (C) (N ¼ 9/group, three replicates). The
ted IL10-secreting T and B cells in the cultures containing WT
analyzed by ﬂow cytometry (D). Mean ± standard error. *P <
Figure 5. Interleukin-10 (IL10)-producing B cells have
greater ability to suppress IL17a than IL10-producing
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requires the presence of IL10-producing T cells.
Next, we investigated the regulatory function of B cells
on T cell subsets. Because CD25þCD4þ T cells have previ-
ously been shown to attenuate chronic T-cell-mediated
colitis,29 we explored whether the regulatory role of
IL10-producing B cells was mediated by IL10-secreting
CD25þCD4þ Treg. We measured cytokines in CBL-
stimulated cocultures of naïve CD25CD4þ T cells from
WT mice, CD25þCD4þ Treg from WT or Il10/ mice, and B
cells from WT or Il10/ mice with Il10/ APC. We found
that WT B cells produced more IL10 than WT CD25CD4þ
or CD25þCD4þ cells alone and that the total amount of IL10
was even higher when cocultured with WT CD25CD4þ
and/or CD25þCD4þ T cells (Figure 4C). The majority of
IL10-positive cells in the cultures containing WT
CD25CD4þ, WT CD25þCD4þ, and WT B cells were B cells
(Figure 4D). The WT but not Il10/ B cells suppressed
IFNg-production by CD25-CD4þ T cells to a similar degree
as WT or Il10/CD25þCD4þ Treg cells. CD25þCD4þ Treg
and WT B cells each suppressed IFNg-secretion, and when
added together, the degree of suppression was greater
(Figure 4C). On the other hand, the presence of Il10/ B
cells enhanced IFNg-production by both CD25CD4þ and
CD25þCD4þ T cells compared with no B cells (Figure 4C).
These data suggest that IL10-producing B cells inhibit TH1
function to a similar degree as CD25þCD4þ Treg cells.
Because IL10-producing myeloid cells also regulate
effector T cells,30,31 we compared the functional capacities
of IL10-producing B cells with APC. Interestingly, while WT
B cells suppress both IFNg and IL17, WT APC decreased
IFNg but paradoxically enhanced IL17-secretion despite
their IL10-secreting capacity (Figure 5), suggesting that
myeloid WT APC are unable to suppress TH17-mediated
immune reactions that are regulated by B cells.antigen-presenting cells (APC). We cocultured 5  105
splenic B6.WT (wild-type) CD25CD4þ T cells with and
without 1  106 B cells from B6.WT or Il10/ knockout (KO)
mice along with 2  105 B6.WT or Il10/ APC. In parallel, 2 
105 (1) or 1 106 (5) WT APC were added to the cultures of
WT CD25CD4þ T cells and Il10/ APC. Cells were stimu-
lated with cecal bacterial lysate for 72 hours and supernatant
levels of IL10, interferon-g (IFNg) and IL17a were measured by
enzyme-linked immunosorbent assay (ELISA). N ¼ 9/group,
three replicates; mean ± standard error. *P < .05; **P < .01.Physiologically activated Interleukin-10-
Producing B Cells Promote the Differentiation
of Naïve CD4þ T Cells into Tr-1 cells by
Interleukin-10-Dependent Mechanisms
We next determined the inﬂuence of IL10-secreting B
cells on the development of regulatory T cells in vitro. To
investigate this, we quantiﬁed induction of Foxp3þ or IL10-
producing (Foxp3neg) Tr-1 cells and T-cell transcripts in
CBL-treated B6.Il10/ APC cocultures with CD25CD4þ T
cells from Vert-X mice (Il10þ/EGFP reporter, IL10-sufﬁcient)
and B cells from B6.WT or Il10/ mice. The WT but not
Il10/ B cells signiﬁcantly suppressed differentiation of
CD25CD4þ T cells into IFNgþ and IL17þ cells (Figure 6A).
Both WT and Il10/ B cells signiﬁcantly increased the
percentage of Foxp3þ T cells (Figure 6A) and Foxp3 mRNA
in reisolated T cells (Figure 6B) consistent with the up-
regulation of intestinal Foxp3þ T cells in DKO mice that
received WT or Il10/ B cells compared with no B cells
(Figure 1E and F). Il17a expression was lower in the
presence of either WT or Il10/ B cells whereas Ifng
expression was decreased only in the presence of WT but
not Il10/ B cells (Figure 6B). Of considerable interest, WTbut not Il10/ B cells enhanced differentiation of naïve T
cells into IL10-producing Tr-1 cells (Figure 6A) and up-
regulated Il10 mRNA expression in reisolated CD4þ T cells
(Figure 6B). The frequency of Tr-1 cells and IL10-secretion
increased and IFNg and IL17a-secretion decreased in the
presence of increasing numbers of WT but not Il10/ B
cells (Figure 6C). Together, these data suggest that the
regulatory capability of IL10-producing B cells is due in part
to their ability to inhibit differentiation of certain effector
T-cell subtypes and promote differentiation of discrete
regulatory T cell subtypes, including Tr-1 cells.
Whether the observed regulatory features of IL10-
producing B cells, including the expansion of Tr-1 cells,
Figure 6. Resident bacteria-activated interleukin-10 (IL10)-producing B cells promote T regulatory-1 (Tr-1) cell-
induction and suppress T helper cell TH1/TH17 differentiation of naïve CD4
D T cells, in vitro. (A) Il10EGFP reporter Vert-X
CD4þ T cells were cocultured with B6.WT (wild type) or Il10/ (knockout) B cells plus B6.Il10/ antigen-presenting cell (APC)
with cecal bacterial lysate (CBL) for 72 hours and percentages of IL17þ, interferon-gþ (IFNgþ), Foxp3þCD4þ T cells, and Tr-1
(IL10þ, Foxp3neg) cells were analyzed by ﬂow cytometry phorbol myristate acetate, ionomycin, and GolgiStop were added in
the last 4 hours of cultures. (N ¼ 9/group, three replicates.) (B) Transcript levels were evaluated in CD4þ T cells that were
reisolated after 24 hours of coculture as described in (A). (N ¼ 6/group, two replicates.) (C) Numbers of Tr-1 cells and cytokine
concentrations in supernatants of CBL-stimulated cocultures containing WT CD4þ T cells, Il10/ APC and no B cells or
increasing numbers of WT or Il10/ B cells are shown. N ¼ 6/group, two replicates. (D) Frequency of Tr-1 cells and cytokine
concentrations in supernatants of CBL-stimulated cocultures containing WT CD4þ T cells, Il10/ B cells and Il10/ APC with
or without increasing concentrations of recombinant IL10. N ¼ 6/group, two replicates; data presented as mean ± standard
error. *P < .05; **P < .01; ***P < .001.
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factors remains unknown. Therefore, we quantiﬁed the
development of Tr-1 cells in CBL-stimulated cocultures of
CD25CD4þ T cells from Vert-X mice, Il10/ B cells and
Il10/ APC in the presence or absence of exogenous re-
combinant IL10. Adding increasing amounts of recombinant
IL10 signiﬁcantly decreased IFNg and IL17a-secretion and
increased Tr-1 cells (Figure 6D). These data indicate that B
cell secretion of IL10 is capable of down-regulating IFNg
and IL17 and inducing Tr-1 cells.Next, we wanted to determine whether IL10-
producing B cells require physical cell contact with T
cells to induce regulatory T cells and suppress inﬂam-
mation. We cocultured naïve CD4þ T cells from Vert-X
mice and Il10/ APC with or without B cells from WT
or Il10/ mice using transwell plates. Interestingly, WT
B cells did not require cell contact with T cells for Tr-1
induction nor suppression of proinﬂammatory cyto-
kines, indicating that IL10 secretion by B cells confers
protection (Figure 7A).
Figure 7. Interleukin-10 (IL10)-producing B cells do not require physical cell contact with T cells to induce T regulatory-
1 (Tr-1) cells and regulate inﬂammation. (A) 5  105 naïve Vert-X CD4þ T cells and 5  105 B6.Il10/ antigen-presenting cell
(APC) (in the lower chamber) were cocultured without or with B6.WT (wild-type) or Il10/ KO (knockout) B cells (either in the
upper or lower chamber) with cecal bacterial lysate (CBL) for 72 hours. (N ¼ 5–6/group, two replicates; mean ± SD. *P < .05,
**P < .01.) (B, C) IL10-producing B cells promote Tr-1 cell-induction in vivo. We cotransferred 5  105 WT naive Vert-X CD4þ T
cells with or without 1  106 B6. B cells from WT or Il10/(KO) mice into SPF B6.Rag2/Il10/ mice. Three weeks later, the
frequency of Tr-1 and Foxp3þCD4þ T-regulatory cells in mesenteric lymph nodes (MLN) (B) and colon lamina propria (LP) (C)
from Rag2/Il10/ mice were assessed by ﬂow cytometry (CD4þ cells gated). N ¼ 8–9/group, two replicates; mean ±
standard error. **P < .01; ***P < .001.
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we hypothesized that WT B cells are also associated with
increased Tr-1 cells in vivo. To test this, we cotransferred
CD25CD4þ T cells from Vert-X mice with or without B cells
from WT or Il10/ mice into DKO recipients and quantiﬁed
colonic and MLN Tr-1 cells and Foxp3þ Treg. While WT, but
not Il10/, B cells signiﬁcantly induced Tr-1 cells in the
colonic LP and MLN, Foxp3þ T cells were induced by B
cells in an IL10-independent fashion (Figure 7B and C).
These results suggest that physiologically activated
IL10-producing B cells may attenuate colitis by selectively
promoting the expansion of immunoregulatory IL10-
producing Tr-1 cells in the intestine.
Induction of T Regulatory-1 Cells by
Interleukin-10-Secreting B Cells Requires
T Cell Interleukin-27 Signaling
Others have shown that IL27 inhibits differentiation of
naïve T cells into TH17 cells and promotes the expansion of
Tr-1 cells through up-regulating c-Maf and aryl hydrocarbon
receptor in naïve T cells.20 Iwasaki et al32 demonstrated that
IL27-driven Tr-1 induction requires early growth response
protein 2 (EGR-2)-mediated B-lymphocyte-induced matu-
ration protein-1 (Blimp-1) induction. Because the presenceof IL10-producing B cells in T-cell cocultures is associated
with increased gene expression of Il10, Cmaf, Ahr, Blimp1,
and Il21 in T cells (Figure 6B), we hypothesized that IL10-
secreting B cells increase Tr-1 cells in an IL27-dependent
manner. To test this, we cotransferred naïve T cells from
WT or Il27ra/ mice with or without B cells from WT or
Il10/ mice into B6 DKO mice. Interestingly, the ability of
WT B cells to inhibit colitis was abrogated in the absence of
IL27-signaling on CD4þ T cells (Figure 8A). Spontaneous
IFNg and IL17a-secretion by colonic tissue explants was
higher and IL10-secretion was lower in mice that received
WT B cells along with Il27ra/CD4þ T cells versus WT
T cells (Figure 8B). Moreover, WT B cells were unable to
induce intestinal Tr-1 cells in the absence of IL27-signaling
(Figure 8C and D). In vitro, neutralization of IL27 dimin-
ished the ability of WT B cells to suppress IFNg-secretion by
T cells and to induce Tr-1 cells (Figure 9A), corresponding
with decreased Ahr and Il10-expression in reisolated T cells
(Figure 9B). Moreover, CD25CD4þ T cells from Il27ra/
mice were unable to differentiate to Tr-1 cells and produced
more IFNg in the presence of IL10-secreting B cells
(Figure 9C). These data suggest that the full ability of IL10-
secreting B cells to stimulate Tr-1-development requires
IL27-signaling in T cells.
Figure 8. Interleukin-10 (IL10)-producing B cells are unable to attenuate intestinal inﬂammation in the absence of T cell
IL27-signaling, in vivo. 5  105 B6.WT (wild-type) or Il27ra/CD25-CD4þ T cells were cotransferred with or without 1  106
B6. B cells from WT or Il10/ knockout (KO) mice into speciﬁc pathogen-free (SPF) B6.Rag2/Il10/ mice. Six weeks later,
colonic inﬂammation was quantiﬁed by total histologic score (A) and cytokine-secretion from colon explant cultures (B).
Frequency of T regulatory-1 (Tr-1) and Foxp3þCD4þ T-regulatory cells in mesenteric lymph nodes (MLN) and colon LP CD4þ T
cells was assessed by ﬂow cytometry (C, D). N ¼ 8–9/group, two replicates; mean ± standard error. *P < .05; **P < .01.
Figure 9. Blockade of interleukin-27 (IL27) decreases IL10-secreting B-cell-mediated T regulatory-1 (Tr-1) induction
in vitro. (A) Frequency of Tr-1 cells and cytokine concentrations in cecal bacterial lysate (CBL)-stimulated cocultures
containing 2.5  105 B6.WT (wild-type) CD25-CD4þ T cells, 5  105 B6.WT or Il10/ B cells and 2.5  105 B6.Il10/ antigen-
presenting cells (APC) with the indicated blocking-antibodies (anti-IL27 or isotype control). N ¼ 9/group, three replicates. (B)
Transcript levels in CD4þ T cells that were reisolated after 24 hours from CBL-stimulated cocultures that contained WT
CD25-CD4þ T cells, WT B cells, Il10/ APC, and the indicated blocking antibodies. (N ¼ 6/group, two replicates.) (C) Fre-
quency of Tr-1 cells and cytokine levels in CBL-stimulated cocultures containing 2.5  105 B6.WT or Il27ra/CD25CD4þ T
cells, 5  105 B6.WT or Il10/ B cells, and 2.5  105 B6.Il10/ APC. N ¼ 6/group, two replicates; mean ± standard error. *P <
.05; ***P < .001.
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Figure 10. Added interleukin-27 (IL27) promotes T helper cell 1 (TH1)-mediated immune responses without affecting
wild-type (WT) B cell-induced T regulatory-1 (Tr-1) cells. 0, 0.1, 1, and 10 ng/mL of recombinant murine IL27 were added to
the cecal bacterial lysate (CBL)-stimulated cell cultures containing 2.5  105 CD25CD4þ T cells from Vert-X mice, 5  105 B
cells from B6.WT or Il10/ mice plus 5  105 B6.Il10/ APC. Tr-1 induction was assessed by ﬂow cytometry and IL10, IFNg,
and IL17a supernatant levels were measured by enzyme-linked immunosorbent assay (ELISA). N ¼ 9/group, three replicates;
mean ± standard error. *P < .05 (vs no recombinant IL27).
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associated with differential Tr-1-induction and anti-
inﬂammatory response by IL10-secreting B cells, naïve
B6.WT T cells and Il10/ APC were cocultured with or
without B6.WT or Il10/ B cells in the presence or absence
of different doses of recombinant IL27. Increasing concen-
tration of recombinant IL27 promoted IFNg-secretion
and decreased IL17a-secretion (Figure 10), whereas
additional recombinant IL27 was not associated with
further Tr-1-induction by WT B cells. These data indicate
that low to moderate concentrations of IL27 are sufﬁcient
for IL10-secreting B cells to induce Tr-1 cells and confer
protection whereas excessive IL27 enhances IFNg-secretion
that may exacerbate TH1-mediated intestinal inﬂammation.
Because IL27 is implicated in the development of Tr-1
cells, we sought to identify the cell-type that secretes IL27
in our in vitro coculture system. Although others have
previously identiﬁed myeloid cells as the primary source of
IL27,15 we detected IL27-secretion by CBL-stimulated B
cells, with no difference between Il10/ and WT cells
(Figure 11A). We also found markedly higher levels of IL27
with cocultured Il10/ APC and Il10/ B cells, which was
abrogated by recombinant IL10. Moreover, the addition of
anti-IL10R-blocking antibody to cocultured WT B cells and
WT APC enhanced IL27-secretion (Figure 11A). The IL27þ B
cells, but not the IL27þ myeloid cells, were expanded inCBL-stimulated versus nonstimulated cocultures, suggesting
that increased IL27 in the cultures containing Il10/ B cells
and Il10/ APC was mainly produced by CBL-stimulated
Il10/ B cells (Figure 11B and C). Together, these data
indicate that CBL induces B cells to secrete IL27, especially
in the presence of APC and absence of IL10, and that IL10,
regardless of the source, controls IL27 secretion.Discussion
We demonstrate a key role for physiologically stimulated
IL10-secreting B cells in mucosal immune homeostasis and
provide a mechanism by which resident intestinal microbial
components induce IL10-dependent regulatory immune
responses that prevent intestinal inﬂammation. Our
in vivo data show that IL10-producing B cells ameliorate
T-cell-mediated experimental colitis depending on IL10-
production by both cotransferred B cells and CD4þ T cells
in the absence of IL10-producing APC.
Previous studies of regulatory B cells in experimental
colitis have characterized subpopulations of B cells that
secrete higher IL10 concentrations. For instance, intestinal
CD1dhigh B cells produce IL10 and attenuate colitis.10
IL10-secreting splenic B10 cells ameliorate acute DSS-
induced colitis,33 a model that does not require the pres-
ence of T cells and microbiota to develop colitis; and
Figure 11. Bacterial ly-
sates induce B cells to
produce interleukin-27
(IL27) in the presence of
antigen-presenting cell
(APC). (A) IL27 concentra-
tions in cecal bacterial
lysate (CBL)-stimulated
cocultures containing wild-
type (WT) or Il10/
knockout (KO) APC and
WT or Il10/ B cells, with
10 mg/mL of anti-IL10-
receptor or isotype anti-
bodies, or 10 ng/mL of re-
combinant IL10. (N ¼ 9/
group, three replicates;
mean ± standard error.
***P < .001.) Representa-
tive ﬁgures (B) and cell
numbers (C) for IL27þ
(p28þEbi3þ) B cells and
CD11bþ myeloid cells in
CBL-stimulated or non-
stimulated cocultures that
contains WT B cells with
WT APC or Il10/ APC
with Il10/ B cells. N ¼ 4/
group, two replicates;
mean ± standard error.
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in Il10/ mice and when cotransferred with CD45RBhigh
T cells into Rag2/ recipients.34 However, our unfractio-
nated IL10-producing B cells were sufﬁcient to suppress
chronic colitis caused by bacteria-activated WT T cells in an
IL10-deﬁcient susceptible host. We found a relatively low
percentage of B10 (CD1dhighCD5þ) phenotype among the
MLN and colonic LP IL10-secreting B cells of recipient mice
(data not shown). The anti-inﬂammatory B cells identiﬁed in
our study likely have a broader phenotype than the small
B10-subset and are most likely physiologically stimulated by
resident microbiota in the recipient’s intestine to differen-
tiate into resident IL10-secreting B cells or plasma cells that
regulate inﬂammation.Because several studies have suggested that regulatory B
cells modulate inﬂammation by inducing Foxp3þ Treg
through glucocorticoid-induced TNFR-related protein
(GITR) or transforming growth factor-b (TGF-b),35,36 we
expected that WT but not Il10/ B cells would attenuate
inﬂammation by inducing intestinal Foxp3þ T cells. How-
ever, our in vivo and in vitro data show that B cells induce
Foxp3þ T cells in an IL10-independent fashion as previously
indicated,35 but Il10/ B cells were not fully protective in
the absence of IL10-secreting APC. Thus, mechanisms by
which WT but not Il10/ B cells suppressed mucosal
inﬂammation required further explanation.
Although cotransferred CD25þCD4þ Treg can ameliorate
TH1/TH17-mediated colitis induced by naïve CD45RB
high T
Figure 12. Proposed regulatory mechanisms of
interleukin-10 (IL10)-producing B cells. Proposed regula-
tory mechanisms of wild-type (WT) B cells (A) compared with
Il10/ B cells (B) or antigen-presenting cell (APC) and T-cell
subsets in the absence of B cells (C). B cells regulate mucosal
inﬂammation by multiple mechanisms, including IL10
secretion-dependent 1) direct suppression of APC proin-
ﬂammatory cytokines, 2) decreasing the proinﬂammatory
cytokines from effector T cells, and 3) stimulating Tr-1 cells in
collaboration with low to moderate concentrations of IL27 as
well as IL10-independent induction of Foxp3þ T-regulatory
cells mediated by glucocorticoid-induced TNFR-related pro-
tein (GITR) or transforming growth fractor-b (TGF-b). In the
absence of IL10 production, B cells produce higher concen-
trations of IL27 and IL12 p40 and activate T helper cells (TH1)
to secrete interferon-g (IFNg), even though they can include
Foxp3þ T-regulatory cells (B).
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unfractionated WT T cells (containing both naïve and
Foxp3þCD25þCD4þ Treg) could not suppress colitis in
Il10/Rag2/ mice in the absence of IL10-producing B
cells or IL10-secreting APC. Previous studies have implicated
a requirement for protective IL10-producing myeloid cells
that induce and maintain Foxp3þ Treg in T cell transfer
colitis models.28,37 In our study, WT B cells ameliorated
T cell-mediated colitis when cotransferred with WT but not
Il10/CD4þ T cells, suggesting that IL10-producing B cells
can replace IL10-secreting APC in activating protective IL10-
producing regulatory CD4þ T cells to confer protection. Our
in vitro transwell study demonstrated that IL10 secretion by
B cells without cell-to-cell contact is sufﬁcient to activate
Tr-1 cells and suppress inﬂammatory cytokine production.
Several studies have demonstrated the capacity of
B cells to activate Tr-1 cells. IL10-producing B cells induced
Tr-1 cells in a rheumatoid arthritis model,38 and TLR2-
activated B cells regulated Helicobacter-induced gastritis
by inducing CD25þCD4þ Tr-1-like cells.39 These studies
addressed the importance of IL10-producing B cells to
control effector and regulatory T cells. Therefore, we
focused on the key mechanisms by which IL10-producing
but not Il10/ B cells induced Tr-1 cells in IBD.
Key ﬁndings of our study were that physiologically
stimulated IL10-secreting B cells induce mucosal Tr-1
cells in an IL27-signaling-dependent manner and
decrease TH1/TH17 immune responses. The biologic role
of IL27 in IBD remains uncertain because IL27 has been
implicated as both a proinﬂammatory and anti-
inﬂammatory cytokine.22–27 However our data suggest
that these pleiotropic protective and inductive effects may
be due to different timing or concentrations of IL27 and
variable presence of IL10 in the various colitis models. B
cells appear to optimally control the regulatory functions
of T cells by secreting IL10 with small amounts of IL27,
but high concentrations of IL27, particularly in the
absence of IL10, enhance IFNg production.
Because IL10-producing myeloid cells can also induce
Tr-1 cells and regulate effector T cells,30,31 we compared the
functional capacities of IL10-producing B cells with APC and
found that WT B cells have a greater ability to induce Tr-1
cells than comparable myeloid APC (data not shown). Of
note, although WT B cells suppress both IFNg and IL17,
WT APC decreased IFNg but paradoxically enhanced
IL17-secretion, despite their IL10-secreting capacity. Thus,
IL10-secreting B cells appear to be more efﬁcient immu-
noregulatory cells than myeloid WT APC in that they sup-
press both TH1 and TH17-mediated immune reactions.
These data indicate that IL10 from several APC sources
(myeloid and B cells) activate Tr-1 cells and that IL10-
secreting B cells and myeloid cells differentially regulate
effector T-cell subsets.
Our in vitro data show that IL10-deﬁcient B cells have
pleiotropic effects on CBL-stimulated CD4þ T cells,
decreasing IL17 while promoting IFNg production. This
effect is consistent with increased IL12p40 production by
CBL-stimulated Il10/ B cells versus WT B cells, suggesting
that the observed increased IFNg in the presence of Il10/B cells is due to higher IL12 secretion by Il10/ B cells. On
the other hand, depleting Il10/ B cells by anti-CD20-
antibodies worsened mucosal inﬂammation in Il10/
mice,35 and bacterial antigen-stimulated Il10/ B cells have
some protection against T-cell-mediated colitis,40 suggesting
IL10-independent regulatory mechanisms of B cells. We
likewise showed slight protection against colitis by Il10/
B cells and IL10-independent induction of Foxp3þ Treg by
B cells.
In conclusion, physiologically activated IL10-secreting B
cells regulate mucosal inﬂammation by multiple mecha-
nisms: suppressing effector APC:T cell activity, decreasing
proinﬂammatory cytokine production, and expanding Tr-1
cells in association with immunosuppressive amounts of
IL27 (Figure 12). B cells induce Foxp3þ Treg in an IL10-
independent manner, but this is not sufﬁcient to maxi-
mally protect against colitis. Overall, IL10-secreting B cells
May 2015 IL10-Producing B Cells in IBD 309have an important role in regulating T-cell function and
ameliorating T-cell-mediated colitis. These ﬁndings provide
new insights into the mechanisms of intestinal immune
homeostasis and may provide new targets for IBD
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